PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of General Medicine, Juntendo University Faculty of Medicine, Japan; Department of Safety and Health Promotion, Juntendo University, Japan.\', \'Department of Palliative Medicine, Juntendo University Graduate School of Medicine, Japan.\', \'Department of Safety and Health Promotion, Juntendo University, Japan.\', \'Department of Pharmacy, Juntendo University Hospital, Japan.\', \'Department of Safety and Health Promotion, Juntendo University, Japan; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan.\', \'Department of General Medicine, Juntendo University Faculty of Medicine, Japan; Department of Safety and Health Promotion, Juntendo University, Japan. Electronic address: naito@juntendo.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00258-010.1016/j.jiac.2021.09.009
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34580011
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all